PGGM Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,133
Closed -$1.72M 364
2023
Q2
$1.72M Sell
14,133
-56,630
-80% -$7.55M 0.03% 287
2023
Q1
$10.9M Buy
70,763
+19,711
+39% +$3.25M 0.18% 104
2022
Q4
$9.17M Sell
51,052
-14,768
-22% -$2.41M 0.16% 124
2022
Q3
$7.78M Buy
+65,820
New +$9.99M 0.14% 142
2022
Q1
$1.13M Hold
4,452
0.01% 345
2021
Q4
$1.13M Buy
4,452
+3,366
+310% +$984K 0.01% 345
2021
Q3
$418K Buy
+1,086
New +$401K ﹤0.01% 351

Other funds holding MRNA

PGGM Investments's MRNA Position: Q3 2023 in Review

PGGM Investments sold out of Moderna (MRNA) in Q3 2023, closing a stake of 14,133 shares — an estimated $1.72M sold.

PGGM Investments first reported a position in MRNA in Q3 2021 and held it in 7 quarters. The position peaked at $10.9M in Q1 2023. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • PGGM Investments reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • PGGM Investments sold 14,133 Moderna shares in Q3 2023, an estimated $1.72M.
  • PGGM Investments first reported a position in Moderna in Q3 2021 and held it in 7 quarters.
  • PGGM Investments's Moderna position peaked at $10.9M in Q1 2023.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on PGGM Investments's 13F filing for Q3 2023, filed 8 Nov 2023.